Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Systech is a leading provider of digital supply chain security and product authentication solutions, specifically tailored for the pharmaceutical and life sciences sectors. The company specializes in serialization, track-and-trace, and anti-counterfeiting technologies that help global manufacturers meet stringent regulatory requirements like the Drug Supply Chain Security Act (DSCSA). Its flagship platform, UniSecure, utilizes non-additive digital e-Fingerprint technology to protect brands from diversion and counterfeiting without requiring changes to existing packaging. In 2020, Systech was acquired by Dover Corporation and integrated into its Markem-Imaje business unit to expand its digital packaging and traceability offerings. The company's solutions are deployed across thousands of packaging lines globally, ensuring the integrity of life-saving medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Systech.